We are live on ! Find out more
CIAM

Caitong International Asset Management Portfolio holdings

AUM $729M
1-Year Est. Return 1,176.98%
This Fund
S&P 500
This Quarter Est. Return
+450.73%
1 Year Est. Return
+1,176.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$144M
AUM Growth
+$4.42M
Cap. Flow
-$25.9M
Cap. Flow %
-17.92%
Top 10 Hldgs %
46.65%
Holding
2,636
New
693
Increased
599
Reduced
567
Closed
752

Top Buys

Rank Stock Value
1
CRWV
CoreWeave
CRWV
+$12.2M
2
NVDA icon
NVIDIA
NVDA
+$8.27M
3
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$4.39M
4
IONQ icon
IonQ
IONQ
+$4.06M
5
TSLA icon
Tesla
TSLA
+$3.37M

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$16.2M
2
AAPL icon
Apple
AAPL
+$14.1M
3
PLUG icon
Plug Power
PLUG
+$6.4M
4
BBAI icon
BigBear.ai
BBAI
+$5.05M
5
MSTR icon
Strategy Inc
MSTR
+$3.86M

Sector Composition

Rank Sector Weight
1 Technology 43.79%
2 Consumer Discretionary 14.1%
3 Healthcare 11.32%
4 Financials 5.96%
5 Industrials 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABUS icon
1876
Arbutus Biopharma
ABUS
$906M
-784
Closed -$2.42K
ACIC icon
1877
American Coastal Insurance
ACIC
$461M
-99
Closed -$1.1K
ACIW icon
1878
ACI Worldwide
ACIW
$5.42B
-17
Closed -$780
ACLS icon
1879
Axcelis
ACLS
$4.42B
-122
Closed -$8.5K
ACMR icon
1880
ACM Research
ACMR
$5.65B
-196
Closed -$5.08K
ACN icon
1881
Accenture
ACN
$109B
-16
Closed -$4.78K
ACRE
1882
Ares Commercial Real Estate
ACRE
$264M
-1,119
Closed -$5.34K
ACRS icon
1883
Aclaris Therapeutics
ACRS
$863M
-1,292
Closed -$1.83K
ADBE icon
1884
Adobe
ADBE
$108B
-398
Closed -$154K
ADEA icon
1885
Adeia
ADEA
$3.16B
-357
Closed -$5.05K
ADPT icon
1886
Adaptive Biotechnologies
ADPT
$3.89B
-1,106
Closed -$12.9K
ADTN icon
1887
Adtran
ADTN
$658M
-46
Closed -$413
ADV icon
1888
Advantage Solutions
ADV
$423M
0
-$1
AEHR icon
1889
Aehr Test Systems
AEHR
$4.02B
-1,114
Closed -$14.4K
AEM icon
1890
Agnico Eagle Mines
AEM
$91.3B
-4
Closed -$476
AEP icon
1891
American Electric Power
AEP
$68.3B
-5
Closed -$519
AEYE icon
1892
AudioEye
AEYE
$72.6M
-111
Closed -$1.29K
AGIO icon
1893
Agios Pharmaceuticals
AGIO
$2B
-21
Closed -$698
AHRT
1894
AH Realty Trust
AHRT
$506M
-241
Closed -$1.66K
AIN icon
1895
Albany International
AIN
$1.82B
-1
Closed -$70
AISP
1896
Airship AI Holdings
AISP
$66.8M
-859
Closed -$5.06K
AKAM icon
1897
Akamai
AKAM
$18B
-83
Closed -$6.62K
AL
1898
DELISTED
Air Lease Corp
AL
-16
Closed -$936
ALB icon
1899
Albemarle
ALB
$15.4B
-43
Closed -$2.69K
ALDX icon
1900
Aldeyra Therapeutics
ALDX
$86.9M
-430
Closed -$1.65K

Similar funds

Caitong International Asset Management's Q3 2025 Portfolio in Review

As of Q3 2025, Caitong International Asset Management held 2,636 positions worth $144M, up 3.2% from $140M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Caitong International Asset Management withdrew a net $25.9M in Q3 2025, closing 752 positions and reducing 567 holdings. Its most notable exit was Apple, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 44% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Caitong International Asset Management opened a new position in CoreWeave worth $14.1M.

  • Caitong International Asset Management's largest Q3 2025 buy was CoreWeave: 102,726 shares worth $14.1M.
  • Caitong International Asset Management added most to NVIDIA in Q3 2025, an estimated $8.27M increase.
  • Caitong International Asset Management's biggest Q3 2025 reduction was Palantir, cutting an estimated $16.2M.
  • Caitong International Asset Management fully exited Apple in Q3 2025, selling an estimated $14.1M.
  • Caitong International Asset Management's ten largest holdings make up 47% of its $144M portfolio in Q3 2025.
  • Caitong International Asset Management opened 693 new positions and closed 752 in Q3 2025.
  • Caitong International Asset Management's portfolio value rose 3.2% quarter-over-quarter to $144M.

Based on Caitong International Asset Management's 13F filing for Q3 2025, filed 19 Nov 2025.